Leaving BNY Website

 

You are leaving the BNY Mellon's Depositary Receipts' Website.
Linked sites are not under the control of The Bank of New York Mellon Corporation or any of its subsidiaries or affiliates (together, the "Company") and the Company is not responsible for the content of any linked site or any link contained in a linked site. If you choose to link to a website not controlled by the Company, you do so entirely at your own risk and the Company makes no warranties, either express or implied, concerning the content of such site, including the accuracy, completeness, reliability or suitability thereof for any particular purpose, nor does the Company warrant that such site or content is free from any claims of copyright, trademark or other infringement of the rights of third parties or that such site or content is devoid of viruses or other contamination. The Company does not guarantee the authenticity of documents on the Internet. Links to other sites do not imply any endorsement of or responsibility for the opinions, ideas, products, information or services offered at such sites, or any representation regarding the content at such sites. The Company reserves the right to terminate any link at any time.

Do you wish to continue to the linked site on these terms?

Stay On Page
Leave Page

© 2025 The Bank of New York Mellon Corporation

Depositary Receipt business and services are conducted through The Bank of New York Mellon.

BNY - DR Legal Disclaimer
  

To learn more about DRs, please contact DRBrokerSolutions@bny.com.

 

The information and data provided herein are provided for general informational purposes only.  BNY does not warrant or guarantee the accuracy, timeliness or completeness of any such information or data.  BNY does not undertake any obligation to update or amend any information or data, and may change, update or amend any information or data at any time without prior notice.

 

BNY provides no advice, recommendation or endorsement with respect to any company or securities.  No information or data is intended to provide legal, tax, accounting, investment, financial, trading or other advice on any matter, and is not to be used as such.  We expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon any information or data, including market value loss on the sale or purchase of securities or other instruments or obligations.

 

Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.

 

BNY collects fees from DR holders pursuant to the terms and conditions of the DRs and any deposit agreement under which they are issued.  From time to time, BNY may make payments to an issuer to reimburse and/or share revenue from the fees collected from DR holders, or waive fees and expenses to an issuer for services provided, generally related to costs and expenses arising out of establishment and maintenance of the DR program.  BNY may pay a rebate to brokers in connection with unsponsored DR issuances; brokers may or may not disclose or pass back some or all of such rebate to the DR investor.  BNY may also use brokers, dealers or other service providers that are affiliates and that may earn or share fees and commissions.

 

BNY may execute DR foreign currency transactions itself or through its affiliates, or the Custodian or the underlying Company may execute foreign currency transactions and pay US dollars to BNY.  In those instances where it executes DR foreign currency transactions itself or through its affiliates, BNY acts as principal counterparty and not as agent, advisor, broker or fiduciary.  In such cases, BNY  has no obligation to obtain the most favorable exchange rate, makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate. BNY earns and retains revenue on its executed foreign currency transactions based on, among other things, the difference between the rate it assigns to the transaction and the rate that it pays and receives for purchases and sales of currencies when buying or selling foreign currency for its own account.  The methodology used by BNY to determine DR conversion rates is available to registered Owners upon request or can be accessed here.  In those instances where BNY's Custodian executes DR foreign currency transactions, the Custodian has no obligation to obtain the most favorable exchange rate or that the method by which the rate will be determined will be the most favorable rate, and BNY makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate.  In certain instances, BNY may receive dividends and other distributions from an issuer of securities underlying DRs in U.S. dollars rather than in a foreign currency.  In such cases, BNY will not engage in or be responsible for any foreign currency transactions and it makes no representation that the rate obtained by an issuer is a favorable rate and it will not be liable for any direct or indirect losses associated with the rate.

 

BNY is a global investments company dedicated to helping its clients manage and service their financial assets throughout the investment lifecycle.  BNY is the corporate brand of The Bank of New York Mellon Corporation (NYSE: BNY).

 

BNY's name, brand and/or trademarks may not be used, copied or reproduced without the prior express written consent of BNY.

 

DEPOSITARY RECEIPTS ARE NOT INSURED BY THE FDIC OR ANY OTHER GOVERNMENT AGENCY, ARE NOT DEPOSITS OR OTHER OBLIGATIONS OF, AND ARE NOT GUARANTEED BY, BNY AND ARE SUBJECT TO INVESTMENT RISKS INCLUDING POSSIBLE LOSS OF PRINCIPAL AMOUNT INVESTED.

 

Please also see "Terms of Use."

ACCEPT

Please enable cookies in your browser if you wish to proceed.

Regulation S Disclaimer

 

Access To This Company Profile Is Restricted To Non-U.S. Persons Outside The United States Within The Meaning Of Regulation S Under The U.S. Securities Act Of 1933, As Amended (The "Securities Act").1

 

This company profile does not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction or under any circumstances in which such offer or solicitation is unlawful.

 

Each person accessing this company profile, by so doing, will be deemed to have acknowledged that: (1) It is not a U.S. person (within the meaning of Regulation S under the Securities Act) and is located outside the U.S. (within the meaning of Regulation S under the Securities Act); and (2) Any securities described herein (A) have not been and will not be registered under the Securities Act or with any securities regulatory authority of any state or other jurisdiction and (B) may not be offered, sold, pledged or otherwise transferred except to persons outside the U.S. in accordance with Regulation S under the Securities Act pursuant to the terms of such securities.

 

If you agree with and accept the foregoing and the Terms of use governing this site, please select "Accept" below. Otherwise, press "Decline" to return to the previous page.

 

1 As defined in the Securities Act, the term "U.S Person" means: (1) any natural person resident in the United States; (2) any partnership or corporation organized or incorporated under the laws of the United States; (3) any estate of which any executor or administrator is a U.S. person; (4) any trust of which any trustee is a U.S. person; (5) any agency or branch of a foreign entity located in the United States; (6) any non-discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary for the benefit or account of a U.S. person; (7) any discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary organized, incorporated, or (if an individual) resident in the United States; and (8) any partnership or corporation if: (A) organized or incorporated under the laws of any foreign jurisdiction; and (B) formed by a U.S. person principally for the purpose of investing in securities not registered under the Securities Act, unless it is organized or incorporated, and owned, by accredited investors (as defined in Rule 501(a)) who are not natural persons, estates or trusts.

I Accept Decline

© 2024 The Bank of New York Mellon Corporation
Depositary Receipt business and services are conducted through The Bank of New York Mellon.

Back to Daily DR Market Summary

StreetAccount Summary - EU Market Recap: FTSE 100 (1.64%) to 10432.33, DAX (1.03%) to 24939.35, CAC40 (1.62%) to 7835.31, STOXX 600 (1.30%) to 626.62

Oct 01 ,2026

  • Synopsis:

    • European indices ended in negative territory, near the session's lows. Latest jump in oil/energy comes amid lack of diplomatic traction in the Middle East, still seemingly overshadowing better flow data. On the macro -front, Final manufacturing PMI in Eurozone revised up slightly, while UK reading revised lower. UK Nationwide house price data underperforms expectations and follows weak BoE mortgage approval update on Wednesday. Swiss inflation also on the agenda. Meanwhile, ECB President Lagarde said she did not rule out possibility of leaving role a few months before term ends. Elsewhere, France's 2027 budget reaches parliament today with OAT-Bund spread at 126 bps, up 40 bps since mid-Sep, and inflation unexpectedly at 3% in Sep (LesEchos). PM Lecornu said France borrowing at 4.8%, a rate not seen since 2008, and has warned lawmakers not to add political instability to an energy-driven rise in rates ahead of presidential election. Note, public debt near record €3.6T. Draft claims €54B of "efforts" and aims to hold deficit at 5%. ~40% of that comes from higher taxes and levies, 60% from spending cuts, including €5.5B on pensions.

    • In M&A news, Fresenius (FRE.GR) acquired the remaining 45% of mAbxience for up to €750M, fully consolidating its biosimilars platform. Land Securities (LAND.LN) is expected to raise equity to fund a £500M acquisition of Metrocentre, while Air France (AF.FP) and Lufthansa (LHA.GR) submitted improved binding offers for a stake in TAP. BT Group (BT.A.LN) is also in focus after reports that Epiris sought a waiver on Openreach payments tied to a potential TalkTalk rescue deal. In corporate news, Sika (SIKA.SW) is hosting an investor day highlighting growth initiatives including its Fast Forward program and the Akkim acquisition.

    • On the reporting front, Continental (CON.GR) published an upbeat pre-close call whilst - in the UK- SSE PL (SSE.LN) issued its H1 trading update indicating it remains on track to deliver its FY26/27 adj EPS target. In Belgium, Colruyt Group (COLR.BB) adopted a more cautious stance on its outlook for the current financial year's operating result. Of note, shares in Capgemini (CAP.FP) closed ~+7% up, lifted by Accenture's strong Q4 earnings

  • Digest:

    • Sectors - STOXX Europe 600:

      • Outperformers: Technology +0.47%, Media +0.34%, Telecom +0.18%, Oil & Gas +0.01%, Utilities (0.57%), Insurance (0.73%), Ind Goods & Svcs (0.80%), Health Care (0.85%), Travel & Leisure (1.21%), Food & Beverage (1.25%)

      • Underperformers: Banks (3.74%), Persnl & HHold Goods (2.35%), Basic Resources (1.96%), Autos & Parts (1.69%), Real Estate (1.64%), Chemicals (1.62%), Financial Svcs (1.48%), Construct & Mtls (1.35%), Retail (1.34%)

    • Macro:

      • US tells France and Germany to release diesel stocks or face US export ban (Reuters)

      • EU countries in crisis talks over release of diesel stocks (FT)

      • Germans' biggest fear is the high cost of living (dw)

      • France Seeks to Win Over Markets and Lawmakers With Deficit Plan (BBG)

      • ECB's Lagarde says 'not a good idea' to run for French president (RTE)

      • UK courts Berlin for fighter jet role after collapse of Franco-German project (Politico)

      • Brexit referendum 'possible' in Labour election manifesto, says Burnham (BBC)

      • UK 30-year gilt yields top 6% for the first time since 1998 (Reuters)

      • Italy's inactivity rate down to record low of 32.7% says Istat (Ansa)

    • Company news:

      • Notable Gainers

        • +31.7% HEALTH.FH (Nightingale Health €1.22, +0.29) -- $6.5M proteomics agreement with Michael J. Fox Foundation for neurodegenerative disease research+

        • +29.2% NOM.NO (Nordic Mining NOK1.15, +0.26) -- approval of temporary discharge permit; CEO resigns, new CEO appointed

        • +10.5% CEL.LN (Celadon Pharmaceuticals £0.76, +0.07) -- investor update

        • +8.2% FTC.LN (Filtronic £2.57, +0.20) -- follow-on order from SpaceX

        • +7.5% GARO.SS (GARO SEK11.80, +0.82) -- to discontinue GARO Entity product family and intensify focus on Electrification

        • +7.4% CAP.FP (Capgemini €112.10, +7.70) -- ACN Q4 earnings sympathy

        • +6.7% ALICA.FP (ICAPE Holding €9.28, +0.58) -- earnings

        • +3.8% KIT.NO (Kitron NOK101.80, +3.75) -- target up at Nordea

        • +2.9% TIN.LN (Cornish Metals £1.05, +0.03) -- positive assay results from drilling programme

        • +2.3% SBO.NO (Selvaag Bolig NOK31.20, +0.70) -- home sales update

        • +1.7% PEEL.LN (Peel Hunt £0.92, +0.02) -- trading update

        • +0.9% SAAB.B.SS (Saab SEK623.20, +5.40) -- BofA upgrade

        • +0.4% CON.GR (Continental €67.40, +0.28) -- Q3 pre-close call

      • Notable Decliners

        • -10.2% COLR.BB (Colruyt Group €35.30, -4.02) -- cautious outlook

        • -6.4% ALUNI.FP (UNIFY Group €1.60, -0.11) -- acquisition

        • -6.3% LNZ.AV (Lenzing €19.50, -1.30) -- cash capital increase

        • -6.2% GAW.LN (Games Workshop Group £168.70, -11.20)

        • -6.1% ZEAL.DC (Zealand Pharma DKK254.50, -16.60) -- Boehringer Ingelheim trial results

        • -5.5% TW.LN (Taylor Wimpey £0.81, -0.05) -- sector move

        • -5.4% NWG.LN (NatWest Group £6.51, -0.37) -- sector move

        • -5.3% BWY.LN (Bellway £20.94, -1.18) -- sector move

        • -5.1% PSN.LN (Persimmon £12.48, -0.67) -- sector move

        • -4.7% BKG.LN (Berkeley Group Holdings £31.90, -1.58) -- sector move

        • -4.7% NSKOG.NO (Norske Skog NOK44.60, -2.20) -- completes transaction with NND

        • -4.6% CABK.SM (CaixaBank €12.03, -0.58) -- sector move

        • -4.5% CBG.LN (Close Brothers Group £3.98, -0.19) -- sector move

        • -4.5% LLOY.LN (Lloyds Banking Group £1.02, -0.05) -- sector move

        • -4.4% BTRW.LN (Barratt Redrow £3.18, -0.15) -- sector move

        • -4.4% MT.NA (ArcelorMittal €56.74, -2.62)

        • -4.2% MB.IM (Mediobanca €27.41, -1.21) -- sector move

        • -4.2% SAN.SM (Banco Santander €11.81, -0.52) -- sector move

        • -4.1% EMG.LN (Man Group £3.16, -0.14) -- sector move

        • -4.1% PANR.LN (Pantheon Resources £0.11, -0.00) -- CEO to step down

        • -4.1% UCG.IM (UniCredit €79.53, -3.37) -- sector move

        • -4.0% HSBA.LN (HSBC Holdings £14.37, -0.61) -- sector move

        • -3.9% INGA.NA (ING Groep €30.25, -1.24) -- sector move

        • -3.9% PVMEZZ.GA (Phoenix Vega Mezz €0.05, -0.00) -- earnings

        • -3.7% ACA.FP (Credit Agricole €16.92, -0.65) -- sector move

        • -3.6% BNP.FP (BNP Paribas €91.54, -3.46) -- sector move

        • -3.5% FSECURE.FH (F-Secure €1.49, -0.05) -- to renew its operating model

        • -3.4% ALCLS.FP (Cellectis SA €1.29, -0.04) -- remarks at Stifel Virtual Cardiometabolic Forum

        • -3.4% ALM.SM (Almirall €10.20, -0.36) -- study results

        • -3.3% EVPL.LN (Everplay £4.40, -0.15) -- holder places 3.33M shares

        • -3.3% PNDORA.DC (Pandora DKK803.00, -27.60) -- CEO comments US demand dampening as inflation worries grow

        • -3.3% VWS.DC (Vestas Wind Systems DKK189.70, -6.45) -- order

        • -3.2% SNI.NO (Stolt-Nielsen NOK362.00, -12.00) -- earnings

        • -3.1% PZC.LN (PZ Cussons £0.95, -0.03) -- trading statement

        • -3.1% UBSG.SW (UBS Group CHF39.06, -1.23) -- Artisan Partners Asset Management sends letter to the board of UBS Group AG, no longer sees Switzerland as desirable location for UBS

        • -3.0% VTY.LN (Vistry Group £2.50, -0.08) -- sector move

        • -2.6% DBK.GR (Deutsche Bank €31.03, -0.83) -- sector move

        • -2.5% VCT.FP (Vicat €58.00, -1.50) -- acquisition

        • -1.9% BREE.LN (Breedon Group £3.17, -0.06) -- CEO to retire; new CEO appointed

        • -1.7% GLE.LN (MJ Gleeson £2.86, -0.05) -- sector move

        • -1.3% KNEBV.FH (Kone €50.52, -0.66) -- plans TK Elevator Europe sale to address antitrust concerns -- Reuters

        • -0.1% STG.DC (Scandinavian Tobacco Group DKK73.90, -0.10) -- completes divestment of BREAK and Moro; raises FY26 FCF guidance

    • EU companies reporting Friday:

      • France: Bonduelle (BON.FP)

      • UK: JD Wetherspoon (JDW.LN)

    • Macro-releases expected tomorrow:

      • Italy Aug retail sales, Spain Sep unemployment change, Eurozone Sep flash CPI, Norway Sep retail sales, Finland Sep HICP rate, Austria Sep HICP rate

  • Data:

    • Economics:

      • Eurozone Aug Unemployment Rate 6.4% vs consensus 6.4% and prior 6.4%

      • Sep Manufacturing

        • Eurozone 52.9 vs preliminary 52.7

        • France 50.6 vs preliminary 50.3

        • Germany 53.9 vs preliminary 54.3

        • UK PMI 51.9 vs preliminary 51.7

        • Spain 51.0 vs consensus 50.1 and prior 49.5

        • Switzerland 55.3 vs consensus 56.0 and prior 57.1

      • Italy Aug Unemployment Rate 6.2% vs consensus 5.8% and prior 5.8%

      • Switzerland

        • Sep CPI y/y +1.0% vs consensus +1.0% and prior +0.8%

        • Aug Retail sales y/y +3.2% vs consensus +2.2% and prior revised to +2.6% from +2.3%

      • UK Sep Nationwide House Price Index y/y +0.8% vs consensus +1.3% and prior +1.6%

    • Markets:

      • WTI Crude (Nov 26): +$2.20 or +2.43% to $92.62

      • €-$ (0.0086) or (0.76%) to 1.1246

      • £-$ (0.0059) or (0.45%) to 1.3206

      • €-£ (0.0025) to 0.8519

      • S&P 500 (0.20%)

      • Performance year-to-date

        • FTSE 100: +5.04%

        • DAX: +1.83%

        • CAC: (3.86%)

        • MIB: +11.78%

        • Stoxx 600: +5.81%

This information and data is provided for general informational purposes only. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to "Terms Of Use".

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE

    • BNY.com Terms of Use Privacy Cookie Notice Manage Cookies Disclaimer CUSIP Disclaimer

    • ©  2025 The Bank of New York Corporation. Depositary Receipt business and services are conducted through The Bank of New York.